U.S. Markets closed

Boston Scientific price target raised to $13 from $10 at Lazard Capital

Lazard Capital raised its price target for Boston Scientific after meeting with management and keeps a Buy rating on the stock. The firm believes new products and the stock buyback could drive shares higher.